Latest Breaking News On - Roche products pty ltd - Page 1 : comparemela.com

TGA Product Information safety updates 13 September

TGA Product Information safety updates 13 September
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Commonwealth of australiaPfizer australia pty ltdPhebra pty ltdLaboratory test abnormalitiesSanofi aventis pty ltdMerch sharpe dohme australia pty ltdSanofi aventis australia pty ltdMedica developments internationalAmgen australia pty ltdLundbeck australia pty ltdRoche products pty ltdAstellas pharma australia pty ltdBayer australia ltdJuno pharmaceuticals pty ltdDear health care professional letterTherapeutic goods administration

South Africa Medical and Surgical Equipment Supply and Manufacturing Industry Report 2023: Multinational Companies with Local Subsidiaries or Partners Dominate the Market

/PRNewswire/ The "The Supply and Manufacture of Medical and Surgical Equipment Industry in South Africa 2023" report has been added to.

South africaSouth africanLaura woodChampion health care pty ltdSouthern medical pty ltdAscendis health ltdPhilips south africa commercial pty ltdDrager south africa pty ltdLodox systems pty ltdE st office hours callAdoption of medical telematic technologyCe mobility wheelchairs pty ltdVertice healthcare pty ltdInnovations pty ltdSurgical supplies pty ltdSafe surgicals pty ltd

Breast cancer drug s pricing in commission s sights

Breast cancer drug s pricing in commission s sights
iol.co.za - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from iol.co.za Daily Mail and Mail on Sunday newspapers.

South africaGenentech incorporatedCompetition commissionAfrican health products regulatory authority sahpraRoche products pty ltdRoche holdingCompetition tribunalHuman epidermal growth factor receptorRoche productsPrescribed minimum benefits

Actemra/RoActemra approved by the European Commission to treat patients with severe COVID-19

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission has extended the marketing authorisation for Actemra®/RoActemra® (tocilizumab) to include the treatment of COVID-19 in adults who are receiving systemic corticosteroids and require supplemental oxygen or mechanical ventilation.1 This .

United statesUnited kingdomLevi garrawayActemra roactemraChugai pharmaceutical co ltdGilead sciences incEuropean unionCommittee for medicinal products human useUniversity of oxfordUniversity of oxford randomised evaluationEuropean commissionDrug administrationWorld health organizationHead of global product developmentJournal of the american medical associationAustralian therapeutic goods administration

F Hoffmann-La Roche Ltd: Actemra/RoActemra approved by the European Commission to treat patients with severe COVID-19

EMA's CHMP recommended the approval yesterdayApproval based on results from four phase III studies in over 5,500 patientsActemra/RoActemra has also been provisionally approved in Australia for the treatment

United statesUnited kingdomNathalie meetzLevi garrawayKarl mahlerSabine borngrGerard tobinBruno eschliSileia urechBirgit masjostLoren kalmActemra roactemraKarsten kleineChugai pharmaceutical co ltdGilead sciences incEuropean union